Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

582
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
582
Randomized Experiments01:13

Randomized Experiments

9.4K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
9.4K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

769
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
769
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

398
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
398
Regression Toward the Mean01:52

Regression Toward the Mean

7.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.3K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

403
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
403

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An integrative mendelian randomisation and drug mechanism framework for target prioritisation and therapeutic repurposing in major depression.

Translational psychiatry·2026
Same author

Factors influencing pharmaceutical companies' decisions to pursue compassionate use programs in the EU: a qualitative study in The Netherlands.

Journal of pharmaceutical policy and practice·2026
Same author

Myosin inhibitors for treatment of hypertrophic cardiomyopathy.

The Cochrane database of systematic reviews·2025
Same author

Individual patient data meta-analysis of placebo-controlled trials of selective serotonin reuptake inhibitors submitted for regulatory approval in adult obsessive-compulsive disorder.

The British journal of psychiatry : the journal of mental science·2025
Same author

Identifying and ranking non-traditional risk factors for cardiovascular disease prediction in people with type 2 diabetes.

Communications medicine·2025
Same author

The impact of operational trial approaches on representativeness: Comparison of decentralized clinical trial participants, conventional trial participants, and patients in daily practice.

Drug discovery today·2025
Same journal

Harms Reporting Was Frequently Incomplete or Discordant in Biomedical Randomized Trials Published in 2023: A Meta-epidemiological Study.

Journal of clinical epidemiology·2026
Same journal

Using an Open Science Checklist in Grant Proposal Reviews to Predict Reproducibility of Funded Publications.

Journal of clinical epidemiology·2026
Same journal

A comparison of five statistical methods used to analyse longitudinal EORTC QLQ-C30 quality of life scores in randomised controlled trials: a simulation study.

Journal of clinical epidemiology·2026
Same journal

Sample Size Determination for Decision-centered Pragmatic Trials.

Journal of clinical epidemiology·2026
Same journal

Many multicenter randomized controlled trials do not account for center effect: a methodological review.

Journal of clinical epidemiology·2026
Same journal

Patient Acceptability of the Modified Zelen Approach to Randomized Trials - A Survey of the CAPS THA Cohort.

Journal of clinical epidemiology·2026
See all related articles

Related Experiment Video

Updated: Apr 19, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Bayesian methods including nonrandomized study data increased the efficiency of postlaunch RCTs.

Amand F Schmidt1, Irene Klugkist2, Olaf H Klungel3

  • 1Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100, P.O. Box 85500, 3508 GA Utrecht, The Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Universiteitsweg 99, P.O. Box 80082, 3508 TB Utrecht, The Netherlands; Department of Farm Animal Health, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 7, 3584 CL Utrecht, The Netherlands; Institute of Cardiovascular Science, Faculty of Population Health, University College London, 222 Euston Road, London NW1 2DA, United Kingdom.

Journal of Clinical Epidemiology
|January 3, 2015
PubMed
Summary
This summary is machine-generated.

Bayesian analysis of randomized clinical trials (RCTs) using prior data from nonrandomized studies can increase the power to detect treatment effects. This approach enhances interaction tests in postlaunch RCTs.

Keywords:
Bayesian statisticsFrequentist statisticsNonrandomized study designObservational study designRandomized controlled trialSimulation

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K

Related Experiment Videos

Last Updated: Apr 19, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmacovigilance

Background:

  • Nonrandomized studies inform postlaunch randomized clinical trials (RCTs) but their data are often excluded from analyses.
  • Ignoring prior nonrandomized study data in RCT subgroup analyses may reduce statistical power.

Purpose of the Study:

  • To explore the bias-power trade-off of Bayesian RCT analysis incorporating nonrandomized study data.
  • To compare frequentist and Bayesian methods for detecting interaction effects in RCTs with subgroup data.

Main Methods:

  • A simulation study compared frequentist and Bayesian analyses.
  • Bayesian analyses utilized noninformative and informative priors.
  • Simulations varied sample size, subgroup proportions, and prior specifications, with differing treatment effects across subgroups.

Main Results:

  • Informative Bayesian analyses showed increased bias but greater power due to reduced posterior variance.
  • When informative priors contradicted RCT data, type 1 error rates reached 100% with 0% power.
  • Bayesian methods incorporating nonrandomized data improved power for interaction tests.

Conclusions:

  • Bayesian methods can enhance the power of interaction tests in postlaunch RCTs by integrating nonrandomized study data.
  • Careful specification of informative priors is crucial to avoid erroneous conclusions.